IN HB1320

Reduces the daily purchase limit for ephedrine and pseudoephedrine from 3 grams per transaction to 3.6 grams per day, and establishes a new 9-gram limit per 30-day period

Removes the June 30, 2012 expiration date on requirements for purchaser identification, logging, and record retention for ephedrine/pseudoephedrine sales

Requires retailers to post warning signs informing customers of criminal penalties for exceeding purchase limits, with amounts listed in both grams and milligrams

Violations remain a Class C misdemeanor, elevated to Class A misdemeanor for repeat offenders

Directs the legislative council to study methamphetamine impacts, PSE electronic tracking system implementation, whether to classify these substances as controlled, and pharmacist notification requirements for brand name medication changes during the 2010 interim